pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›AMXT-1501 + eflornithine hydrochloride
drug · small molecule
save

AMXT-1501 + eflornithine hydrochloride

Phase 2updated 5mo ago
by Aminex Therapeutics Inc🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 5
  • tagGlioblastoma4 co-mentions · 1 sources
  • companyMayo Clinic1 co-mentions · 1 sources
  • tagOncology1 co-mentions · 1 sources
  • drugeflornithine1 co-mentions · 1 sources
  • drugeflornithine hydrochloride1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.

targets

Ornithine decarboxylase

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

trade names
Iwilfin, Ornidyl, Vaniqa
generic
eflornithine hydrochloride
MOA
Ornithine decarboxylase inhibitor
indication
Metastatic Breast Cancer
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 3h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?